KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.99

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in children aged 10-12 years: phase III randomized trial complementary analysis of immune persistence 3-6 years after priming.

James Peterson, Katherine Galarza, Siham Bchir, Celine Zocchetti, Isabelle Bertrand-Gerentes, Betzana Zambrano

Pediatr Res 97(6) 1800-1802

PMID39672823
PMCIDPMC12122353
DOI10.1038/s41390-024-03760-w
发表日期2024-12-13
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要

摘要

Immune persistence following primary vaccination with a single dose of meningococcal quadrivalent conjugate vaccines, MenACYW-TT/MCV4-CRM, at age 10-12 years was demonstrated. Most participants primed with MenACYW-TT and MCV4-CRM maintained seroprotective titers against all serogroups, suggesting continued protection. Priming with MenACYW-TT resulted in higher persistent titers for serogroups C, W, and Y than MCV4-CRM. A MenACYW-TT booster induced a robust immune response; almost all participants achieved seroprotection against all serogroups. This analysis supports the ACIP recommendations for routine administration of a primary dose of a meningococcal ACWY conjugate vaccine at 11-12 years, with a booster dose at 16 years.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。